# FDA 483 - Adam Peyton, D.O. - October 26, 2023

Source: https://www.keypedia.com/records/483/adam-peyton-do/092f7c78-a58a-40c2-b7ac-a77ec66c58ad

> FDA 483 for Adam Peyton, D.O. on October 26, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Adam Peyton, D.O.
- Inspection Date: 2023-10-26
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Northeast Clinical Research Center, LLC in Bethlehem, PA, a clinical investigator site, revealed significant deviations from investigational plans and good clinical practices. Observations included investigations not conducted according to the signed statement of investigator, with unqualified personnel performing safety assessments and physical examinations, and a lack of proper clinical investigator oversight. Additionally, the firm failed to maintain adequate and accurate case histories and source documentation regarding study activities and informed consent processes.

## Related Officers

- [investigator](https://www.keypedia.com/people/gabrielle-j-swain/55f33430-41dc-4fae-bac0-ec6ea340feb6)

Company: https://www.keypedia.com/companies/adam-peyton-do/c52cb1b2-b817-402b-8f34-13bdd0c67a8a

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8